Clinical Trial Update: Glyaderm Clinical Evaluation Multicenter Study [Phase 3]

View source ↗

Summary

Phase 3 multicenter evaluation of Glyaderm for full-thickness burns was terminated in this trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Glyaderm

Snippet

Sponsor: Euro Tissue Bank | Conditions: Full-thickness Skin Loss Due to Burn, Unspecified Site | Phase 3 | Status: TERMINATED